Neocande Tablet 32 mg (Candesartan Cilexetil)

Adult dose

For essential hypertension, the initial and maintenance dosage is 8 to 16 mg of oral candesartan cilexetil once daily. If blood pressure control is insufficient after 4 weeks of 16 mg treatment, the dose may be increased to a maximum of 32 mg once daily. For heart failure, the initial dosage is 4 mg once daily, and it may be doubled every two weeks to a maximum of 32 mg once daily.

Child dose

Safety and efficacy in patients aged 18 years and younger have not been established.

This medication can cause serious harm to the fetus and newborn if taken by pregnant women, so it must be discontinued immediately upon confirmation of pregnancy. Persons with allergies to this medication or its components, those who are pregnant or breastfeeding, individuals with severe liver dysfunction or biliary obstruction, and those with specific genetic disorders should not take this medication. Elderly patients, individuals with hyperkalemia, those with liver dysfunction, patients with heart valve disease or cerebrovascular disorders, and patients with decreased kidney function should use this medication with caution and require regular monitoring. As this medication lowers blood pressure, symptoms of hypotension may occur, and dizziness or fatigue may arise, so caution is advised while driving or operating machinery. While taking this medication, serum potassium and kidney function should be monitored periodically to ensure no abnormalities arise, especially when used with other antihypertensive drugs or potassium-sparing diuretics. This medication may occasionally cause side effects such as skin rash, itching, difficulty breathing, muscle pain, gastrointestinal disturbances, etc., so if any abnormal symptoms occur, consult a healthcare professional immediately. Women planning pregnancy or who may become pregnant should discuss this medication with their physician before use, and breastfeeding women should also avoid taking this medication. Overdosage may result in hypotension, dizziness, rapid heartbeat, etc., and prompt medical attention should be sought. The safety and efficacy in children and adolescents have not been sufficiently established, so it is advisable not to use this age group. This medication should be stored out of reach of children and should be kept in its original container to maintain its quality.

Serious side effects

Hives, severe swelling (angioedema), difficulty breathing (dyspnea), cold sweat, severe rash with fever, blisters, skin peeling, pain in the oral/ocular mucosa, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, significantly reduced urine output, severe systemic swelling and increased blood pressure, angioedema (face, lips, tongue,

Mild side effects

Dizziness, low back pain, respiratory infections (upper respiratory infections, pharyngitis, rhinitis), fatigue, peripheral edema, chest pain, headache, bronchitis, cough, sinusitis, nausea, abdominal pain, diarrhea, vomiting, joint pain, proteinuria, weakness, fever, altered sensation, indigestion, gastroenteritis, tachycardia, palpitations, increased creatine kinase, hyperglycemia, hypertriglyceridemia, hyperuricemia, muscle pain, epistaxis, anxiety, depression, drowsiness, rash, increased sweating, hematuria,

This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. Additionally, it is important to maintain storage at room temperature between 1°C and 30°C to preserve its efficacy.

Appearance

Pink, round, biconvex tablets

Package unit

30 tablets/bottle, 100 tablets/bottle